29 January 2024
AdvancedAdvT Limited
Completion of Disposal of Synaptic Software Limited
AdvancedAdvT Limited (AIM: ADVT, "AdvT", the "Company"), the international software solutions provider for the business solutions, healthcare compliance, and human capital management sectors, announces that it has completed the disposal of Synaptic Software Limited following FCA approval. Full details of the disposal were set out in the Company's AIM admission document published on 8 January 2024, which is available on its website at www.advancedadvt.com.
Enquiries:
| AdvancedAdvT Limited | |
| Vin Murria, Chairperson Gavin Hugill, Chief Financial Officer | c/o Meare Consulting |
| | |
| Singer Capital Markets (Nominated Adviser and Broker) | Tel: 020 7496 3000 |
| Philip Davies / Asha Chotai / Sam Butcher | |
| | |
| KK Advisory (Investor Relations) | Tel: 020 7039 1901 |
| Kam Bansil | |
| Meare Consulting | |
| Adrian Duffield | Tel: 07990 858548 |
Note to Editors
AdvancedAdvT Limited (AdvT) provides software solutions and platforms across two business transformational areas: business solutions & healthcare compliance, and human capital management.
The Group's operations are IBSS (financial management software), CHKS (AI based healthcare intelligence compliance and accreditation software), Retain (global resource planning and talent management software) and WFM (workforce management software provider).
AdvT is an agent for change. The Group enables the delivery of Artificial Intelligence ("AI"), data analytics and business intelligence, all of which are key future drivers for growth in these sectors where long term digitisation trends are set to transform the workplace for professionals.
AdvT is developing both organically and through acquisitions, by expanding its presence across adjacent markets, geographical boundaries and digital sectors.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.